Cold Chain Management - The Latest Regulatory Requirements for Product Distribution in the USA, Canada, and the EU; Detailed Analysis of the EU GDP Guidance

Live, Interactive Training Webinar

Date: Wednesday February 20, 2019
Time: 10:30am - 12:30pm ET (New York Time)
Instructor: Peter Calcott Ph.D. Biography>>>

Member Registration ►

Registration Form ►

Product distribution has been around as long as we have been making drugs for sale to customers. It is the final step in the supply chain, often out of our immediate control. And as such, it is a weak link in the process. With the introduction of more labile and complex products, we are presented with medicines that must be protected from the environment and degradation. These new medicines often require low temperature storage and transport and hence the term Cold Chain Management was employed. To assure that these medicines stay in these strict requirement ranges takes complex controls and processes. Some can be validated to assure consistency while others by their nature cannot but rely on monitoring to assure compliance.

This live training webinar will provide valuable information on the requirements for product distribution as defined by the regulations in USA, Canada and the EU as the agencies reinterpret them and begin to more strongly enforce them. It will also include a detailed analysis of the 2013 EU GDP Guidance recently enacted. We will discuss the absence of guidances in the US which solely relies on a simple chapter in USP. This will enable you to see how successful companies can translate these requirements and changing agency stance into workable processes that are compliant with the regulations and yet efficient from a business perspective, meeting their customer needs. We will show you simple ways to assess from a risk perspective the steps in the distribution chain to identify your weak links and also areas where you are overdoing controls. We will present criteria you can use to assure you validate where appropriate and monitor where necessary. You will be able to benchmark your processes against those of successful companies so you can easily make improvements. You will also see how companies run foul of the agencies’ new interpretations resulting in warning letters and how from this information you will be able to assure that you do not suffer the same fate.

Learning Benefits:
-How the supply chain links to distribution and where cold chain management is essential.
-What components are the most vulnerable and how to remedy.
-What steps can and can not be validated.
-When to monitor your product and when validation is sufficient.
-Why clinical trial material distribution is more risky than commercial.
-What the new European regulations are saying and how it can help you.
-How your stability groups can help you minimize risk.
-Where companies go wrong and get into regulatory hot water and how to avoid it yourself.

Regulations that will be Covered:
Each country has its own specific sets of regulations. Below are citations from ICH and examples of regulations that are applicable to the inspection and response processes and philosophy:
Code of Federal Regulations 21 sections 210, 211 for Biological products and Drugs and 600 series for Biologicals in addition for USA.
EMA Eudralex Volumes 1, 2, 3, 4, 9 for Drugs and Biologics in EU.
International Conference on Harmonisation Quality Series Q1 through Q10 for USA, EU, Japan and other countries with an emphasis on ICH Q7a.

Webinar outline and time breakdown:

Time*
10:15 AM Log In Period
10:30 AM Introduction
10:40 AM How Distribution fits into the Supply Chain and why it is a weak link,
The regulations governing and controlling Product Distribution - GDP,
The new EU Guidance on GDP and what it means,
How to manage the contractor of this service,
Room temperature versus cold chain distribution - the challenges,
11:30 AM Break
11:40 AM Steps in the process - risk analysis,
How to protect your product,
Monitoring versus validation,
Stability program and how it helps distribution assurance,
Challenges specific to clinical trial material distribution,
Where companies go wrong and how to avoid their problems,
Conclusions,
12:30 PM Live Questions & Discussion

*Please note all times are Eastern Time (New York Time)

This live training webinar includes the following for each registered attendee:

  • A copy of the presentation slides
  • A certificate of participation for attendee training records

Who should attend:
The following individuals or disciplines will benefit from attending this Webinar:

  • Quality Assurance personnel
  • Quality Control personnel
  • Manufacturing management and scientists
  • Senior Management
  • Regulatory Affairs Professionals
  • Logistics and Procurement Management
  • Project Managers working in the CMC arena

Registration Form ►


Instructor: Peter Calcott Ph.D.

Peter H. Calcott, Ph.D. is President, Calcott Consulting which is focused on delivering solutions to pharmaceutical and biotechnology companies in the areas of corporate strategy, supply chain, quality, clinical development, regulatory affairs, corporate compliance and enterprise e-solutions. He is also an Academic Program Developer for the University of California, Berkeley’s Biotechnology and Pharmaceutics Postgraduate Programs. Prior to this he was VP at the executive team level at PDL BioPharma where he was responsible for development and implementation of Quality & Compliance strategy across the corporation… Full Bio>>>

 

 

Course Number: 311

System Requirements:

All Pharma Webinars live training programs audio and visual are delivered via Cisco WebEx with basic system requirements of a computer with internet access and a telephone to access the audio portion of the presentations. You can choose to access the audio through your computer.

Live Training Benefits:

• Pharma Webinars training webinars and programs are presented exclusively as live events only.

• Designed and delivered based on e-learning best practices, Pharma Webinars' live training webinars and programs are as effective as in person training.

• Live training webinars and multi-part training programs are strictly educational based, and do not promote or endorse any products or services whatsoever.

• An interactive live Q&A and discussion period is included in each live training presentation. Questions can also be submitted to the speaker via email both prior to and following the live training webinar as a means of improving participant experience, and ensuring successful topic comprehension.

• Live presentations ensure that all live training webinars and programs are engaging and informative, allowing trainees to exchange ideas through audio conferencing and live chat during each presentation in real time. Each live training session includes a dedicated live Q&A period allowing trainees to interact directly with the instructor, with quick feedback providing them with concrete understanding of the answers and the training subject itself.

• Each Pharma Webinars live training webinar and program content is updated on regular basis to provide the latest regulatory, operational and technological trends in the international pharmaceutical arena. As regulatory expectations, guidance, or industry trends change, so does our training in order to reflect those changes as soon as the changes are released.

• Pharma Webinars' instructors are the most recognized subject matter experts in the industry who are selected based on very strict qualification criteria. They are coached on the latest e-learning speaking methods in order to make each presentation engaging, memorable and very effective.

• Each registered attendee receives an exact copy of the presentation slides and other course handouts significantly reducing the learning curve as trainees can refer back to this material in the future.

• All trainees receive a Certificate of Attendance for each live training webinar and program they attend to be kept for training records.


Client Testimonials:

"The live webinar was very useful to our team, the content was relevant and the instructor was very knowledgeable" QC Microbiology Supervisor, NJ

"We were very satisfied with the live presentation; we appreciated the speaker staying on to answer all of our questions" QA Director, MA

"Our group enjoyed the live presentation and found the experience much more engaging and worthwhile than any recorded webcasts" Sr Training Manager, CA

"This was my first live training, I found it easy to connect, participate and very useful" Laboratory Analyst, PA

"We had our entire department attend this training program and found it to be very useful, I am very satisfied with the speaker's ability to keep the audience engaged" QC Manager, NY

"Given how recent the content of the webinar was, our team members were very happy with the relevance of the training" VP Clinical Operations, CA

"Is my first time to attend training, I enjoy it very much" Sr Manager, Korea

"Our department found the level of interactivity between the audience and the instructor far beyond that of any other online training that we have attended before. Well done" Director Regulatory Affairs, ON

"Our interest group was spread out over three locations and we were able to participate simultaneously and interact very easily" Lead Compliance Manager, IL

"Well satisfied with the presentation. Our team found the speaker's level of knowledge and his ability to translate that knowledge to our processes very valuable" VP Quality Operations, NC

"We were impressed with the quality of the presentation, and despite our being located in Europe we were able to participate without a hitch" QC Manager, Ireland